News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

San Diego's Lumena Pharmaceuticals Files For $75 Million IPO To Fund Liver Drug Trials


4/4/2014 6:54:40 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Lumena Pharmaceuticals, a clinical-stage biotech developing candidates for rare liver diseases, filed on Wednesday with the SEC to raise up to $75 million in an initial public offering. The San Diego, CA-based company, which was founded in 2011, plans to list on the NASDAQ under the symbol LIVR. Lumena Pharmaceuticals initially filed confidentially on February 28, 2014. Citi, Cowen & Company and Leerink Partners are the joint bookrunners on the deal. No pricing terms were disclosed.

Help employers find you! Check out all the jobs and post your resume.

Read at Nasdaq

comments powered by Disqus
Nasdaq
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES